HEART FAILURE NYHA CLASS II
Clinical trials for HEART FAILURE NYHA CLASS II explained in plain language.
Never miss a new study
Get alerted when new HEART FAILURE NYHA CLASS II trials appear
Sign up with your email to follow new studies for HEART FAILURE NYHA CLASS II, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Heart failure breakthrough? implanted device aims to slash deaths and hospital stays
Disease control Not yet recruitingThis large study is testing whether adding a small implanted device called Barostim helps people with moderate heart failure live longer and stay out of the hospital. It will compare the device plus usual medications against medications alone in 2500 participants over two years. …
Matched conditions: HEART FAILURE NYHA CLASS II
Phase: NA • Sponsor: CVRx, Inc. • Aim: Disease control
Last updated Mar 30, 2026 14:34 UTC
-
Digital heart monitor aims to keep patients out of hospital
Disease control Not yet recruitingThis study is testing a new digital alert system for people with heart failure who have a special implanted heart device. The system analyzes data from the device and sends alerts to the healthcare team, aiming to spot problems early and adjust treatment. Researchers want to see …
Matched conditions: HEART FAILURE NYHA CLASS II
Phase: NA • Sponsor: Implicity • Aim: Disease control
Last updated Mar 30, 2026 14:30 UTC